SII-Onco-BCG

SII-Onco-BCG 40mg Injection

The SII-Onco-BCG 40mg Injection is a powerful immunotherapy used to treat and prevent the recurrence of bladder cancer. It contains a weakened, live culture of the BCG bacteria, which activates the body’s immune response to help destroy cancer cells.

Uses:

• Treatment of Primary or Recurrent Bladder Cancer: This injection is administered directly into the bladder to treat primary or recurrent bladder cancer.
• Prevention of Bladder Cancer Recurrence: It is also used to prevent the recurrence of bladder cancer following transurethral resection.

Side Effects:

Common side effects include dysuria, urine frequency, fever, chills, cystitis, and hematuria. It is essential to monitor these symptoms closely and consult an infectious disease specialist if you experience any unusual reactions..

Safety:

The injection is generally safe for geriatric patients, but older individuals may show greater sensitivity to BCG. There is no data available on its safety in pediatric patients..

Administration:

The injection is administered directly into the bloodstream, and its effects can be observed within 1 to 2 minutes of administration..

Storage and Disposal:

The product should be stored in a refrigerator and handled safely to maintain its potency..

This injection is a crucial tool in the fight against bladder cancer, offering a targeted and effective treatment option for patients. Always consult with a healthcare professional before using any medication, especially one as specific as the SII-Onco-BCG 40mg Injection.